P. Murali Doraiswamy, MBBS

Professor of Psychiatry and Behavioral Sciences
Director, Neurocognitive Disorders Program
Professor in Medicine
Faculty Network Member of the Duke Institute for Brain Sciences
Affiliate of the Duke Initiative for Science & Society
Campus mail 3550 Hosp South, Durham, NC 27710

Murali Doraiswamy MBBS FRCP is professor of psychiatry and professor in medicine at the Duke University School of Medicine where he is a highly respected physician neuroscientist at the Duke Institute for Brain Sciences. He specializes in the areas of brain health and personalized medicine and leads a clinical trials unit in developing novel personal diagnostics and therapeutics for cognitive enhancement and mental well-being. Prof Doraiswamy has been an advisor to leading government agencies, businesses and advocacy groups. He has served as the chair of the World Economic Forum’s Global Agenda Council on Brain Research and lectured at leading global forums to advance the forefront of neuroscience research.  Moreover as co-author of a popular book The Alzheimer’s Action Plan and co-author on more than 350 publications, he has received several awards in recognition of his scientific work and his involvement in pivotal landmark trials that have helped develop many modern neurotherapeutics. Additionally, he is a leading advocate for increasing funding for brain and behavioral research to help address great looming challenges in society posed by modern developments in the 21st century. His research has been featured in media outlets such as BBC, The New York Times, Scientific American, The Wall Street Journal, National Public Radio, CBS Evening news, The Dr Oz Show, Oprah, and TIME. He has appeared in acclaimed documentaries such as (Dis)Honesty: The Truth about Lies and Mysteries of the Brain.

  

Education and Training

  • M.B.B.S., University of Madras (India), 1987

Grants

Publications

Lin, Katherine Amy, and P Murali Doraiswamy. “When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer's Disease.” Front Neurol 5 (2014): 288. https://doi.org/10.3389/fneur.2014.00288.

PMID
25628598
Full Text

Johnson, Keith A., Reisa A. Sperling, Christopher M. Gidicsin, Jeremy S. Carmasin, Jacqueline E. Maye, Ralph E. Coleman, Eric M. Reiman, et al. “Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.” Alzheimers Dement 9, no. 5 Suppl (October 2013): S72–83. https://doi.org/10.1016/j.jalz.2012.10.007.

PMID
23375563
Full Text

Klinger, Rebecca Y., Olga G. James, Terence Z. Wong, Mark F. Newman, P Murali Doraiswamy, and Joseph P. Mathew. “Cortical β-amyloid levels and neurocognitive performance after cardiac surgery.” Bmj Open 3, no. 9 (September 20, 2013): e003669. https://doi.org/10.1136/bmjopen-2013-003669.

PMID
24056491
Full Text

Murphy, Kelly R., Susan M. Landau, Kingshuk Roy Choudhury, Christopher A. Hostage, Katie S. Shpanskaya, Haris I. Sair, Jeffrey R. Petrella, Terence Z. Wong, P Murali Doraiswamy, and P Murali Alzheimer’s Disease Neuroimaging Initiative. “Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.” Neuroimage 78 (September 2013): 474–80. https://doi.org/10.1016/j.neuroimage.2013.04.048.

PMID
23624169
Full Text

Atluri, Gowtham, Kanchana Padmanabhan, Gang Fang, Michael Steinbach, Jeffrey R. Petrella, Kelvin Lim, Angus Macdonald, Nagiza F. Samatova, P Murali Doraiswamy, and Vipin Kumar. “Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack.” Neuroimage Clin 3 (August 7, 2013): 123–31. https://doi.org/10.1016/j.nicl.2013.07.004.

PMID
24179856
Full Text

Hoffman, Keith B., Andrea Demakas, Colin B. Erdman, Mo Dimbil, and P Murali Doraiswamy. “Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.” Bmj 347 (July 23, 2013): f4656. https://doi.org/10.1136/bmj.f4656.

PMID
23881998
Full Text

Motsinger-Reif, Alison A., Hongjie Zhu, Mitchel A. Kling, Wayne Matson, Swati Sharma, Oliver Fiehn, David M. Reif, et al. “Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging.” Acta Neuropathol Commun 1 (June 27, 2013): 28. https://doi.org/10.1186/2051-5960-1-28.

PMID
24252434
Full Text

Sternberg, D. A., K. Ballard, J. L. Hardy, B. Katz, M. M. Doraiswamy, and M. D. Scanlon. “The largest human cognitive performance dataset reveals insights into the effects of lifestyle factors and aging.” Frontiers in Human Neuroscience, no. JUN (June 3, 2013). https://doi.org/10.3389/fnhum.2013.00292.

Full Text

Pages